LABETALOL HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a delivery order under basic contract SPE2DX-25-D-8022 to CARDINAL HEALTH, INC. (CAGE 00E55) for the procurement of two units of LABETALOL HYDROCHLORIDE INJECTION (NSN 6505012447982, NDC 00143-9622-01) at a total contract value of $12.28. The award was issued on July 17, 2026, with delivery required FOB destination to two specified locations: one for parcel post at 73 Eastern Point Rd, Groton, CT 06340-4905, and one for freight shipping at 25 Norwich Westerly Road, North Stonington, CT 06359, both under the identifier N27164 and attention to PCU 801. The contractor is responsible for all transportation costs and must ship via the fastest traceable means, with parcel post explicitly prohibited. Inspection and acceptance occur at the destination point by an authorized government representative, with strict compliance required to contract specifications and zero tolerance for quantity variance. The item is delivered under the DoD unit of issue system, and no specific packaging, preservation, or labeling standards beyond mandatory contract and delivery order number markings are prescribed. Payment is processed by the Defense Finance and Accounting Service in Columbus, Ohio, using accounting code BX: 97X4930 5CBX 001 2620 S33189 and agency code 97AS, with electronic award transmission confirmed via EDI. The contracting officer is Lisa Quinn, with Michelle Pampel as a local administrative contact; no COR or COTR is designated. The procurement is consistent with LPTA practices due to the low value and commercial-off-the-shelf nature of the pharmaceutical item, with no socioeconomic set-asides, special certifications, or subcontracting requirements indicated. The underlying contract is an IDIQ vehicle, though no contract type is formally stated, and there are no options, modifications, or extended performance periods specified in this order.